Paper · 70501
Specificity of cytotoxic effector cells directed against trinitrobenzene sulfonate-modified syngeneic cells. Failure to recognize cell surface-bound trinitrophenyl dextran.
Henkart PA and 2 others. J Exp Med, 1977. Cited by 17 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Specificity of cytotoxic effector cells directed against trinitrobenzene sulfonate-modified syngeneic cells. Failure to recognize cell surface-bound trinitrophenyl dextran. Papers, record 70501. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/70501
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Specificity of cytotoxic effector cells directed against trinitrobenzene sulfonate-modified syngeneic cells. Failure to recognize cell surface-bound trinitrophenyl dextran.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunity, Cellular | Major topic |
| Nitrobenzenes | Major topic |
| Spleen | Major topic |
| Trinitrobenzenes | Major topic |
| Trinitrobenzenesulfonic Acid | Major topic |
| Animals | |
| Cell Membrane | |
| Cytotoxicity Tests, Immunologic | |
| Dextrans | |
| Dose-Response Relationship, Immunologic | |
| Epitopes | |
| Male | |
| Mice | |
| Structure-Activity Relationship |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References14
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,079,035 | Thymus-independent antigens: the preparation of covalent, hapten-ficoll conjugates. | J Immunol | 1975 | https://conductscience.org/library/papers/1079035 | PubMed |
| 2 | 1,079,848 | On the role of the H-2 histocompatibility complex in determining the specificity of cytotoxic effector cells sensitized against syngeneic trinitrophenyl-modified targets. | J Exp Med | 1975 | https://conductscience.org/library/papers/1079848 | PubMed |
| 3 | 1,082,923 | Virus and trinitrophenol hapten-specific T-cell-mediated cytotoxicity against H-2 incompatible target cells. | J Exp Med | 1976 | https://conductscience.org/library/papers/1082923 | PubMed |
| 4 | 1,083,956 | Cytotoxic T lymphocytes recognise allogeneic tolerated TNP-conjugated cells. | Nature | 1976 | https://conductscience.org/library/papers/1083956 | PubMed |
| 5 | 1,244,419 | Cell-mediated lympholysis of trinitrophenyl-modified autologous lymphocytes. Confirmation of genetic control of response to trinitrophenyl-modified H-2 antigens by the use of anti-H-2 and anti-Ia antibodies. | J Exp Med | 1976 | https://conductscience.org/library/papers/1244419 | PubMed |
| 6 | 14,564,721 | Use of esters of N-hydroxysuccinimide in the synthesis of N-acylamino acids. | J Lipid Res | 1967 | https://conductscience.org/library/papers/14564721 | PubMed |
| 7 | 4,547,153 | Cell-mediated cytotoxicity to trinitrophenyl-modified syngeneic lymphocytes. | Eur J Immunol | 1974 | https://conductscience.org/library/papers/4547153 | PubMed |
| 8 | 4,547,543 | Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytic choriomeningitis. | Nature | 1974 | https://conductscience.org/library/papers/4547543 | PubMed |
| 9 | 52,308 | Analysis of cell populations with a fluorescence-activated cell sorter. | Ann N Y Acad Sci | 1975 | https://conductscience.org/library/papers/52308 | PubMed |
| 10 | 53,266 | Cell-mediated lympholysis of N-(3-nitro-4-hydroxy-5-iodophenylacetyl)-beta-anaylglycylglycyl-modified autologous lymphocytes. Effector cell specificity to modified cell surface components controlled by the H-2K and H-2D serological regions of the murine major histocompatibility complex. | J Exp Med | 1976 | https://conductscience.org/library/papers/53266 | PubMed |
1 to 10 of 14
See all 14 referencesCited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 22,567,140 | A novel antibody-based biomarker for chronic algal toxin exposure and sub-acute neurotoxicity. | PLoS One | 2012 | https://conductscience.org/library/papers/22567140 | PubMed |
| 311,817 | Specificity of cytotoxicity T cells directed to influenza virus hemagglutinin. | J Exp Med | 1979 | https://conductscience.org/library/papers/311817 | PubMed |
| 221,897 | Specificity of memory cells raised against trinitrophenyl-conjugated syngeneic cells. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/221897 | PubMed |
| 109,569 | H-2-linked genetic control of murine T-cell-mediated lympholysis to autologous cells modified with low concentrations of trinitrobenzene sulfonate. | J Exp Med | 1979 | https://conductscience.org/library/papers/109569 | PubMed |
| 75,237 | H-2-restricted cytotoxic effectors generated in vitro by the addition of trinitrophenyl-conjugated soluble proteins. | J Exp Med | 1978 | https://conductscience.org/library/papers/75237 | PubMed |
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/70501
GET https://conductscience.org/api/papers/v1/70501/authors